Vale and DUBAL Partner in Alumina Project

Companhia Vale do Rio Doce (Vale) announces that it has entered into a share purchase agreement with Dubai Aluminium Company Limited (DUBAL), which operates one of the largest single site aluminum smelters in the world and the industrial flagship of Dubai, to become a partner in its subsidiary Companhia de Alumina do Pará (CAP). The transaction is subject to the fulfillment of certain conditions.

As a consequence, Vale will hold 61% of the total capital of CAP, Hydro Aluminium (Hydro) - one of the largest global producers of aluminum and aluminum products - 20%, and DUBAL 19%.

CAP will be responsible for the implementation and operation of an alumina refinery, located in Barcarena, 5 km away from the alumina refinery of our subsidiary Alunorte. The initial production capacity of this refinery will be 1.86 million metric tons per year of alumina, through two lines, each one of 930,000 tons per year. The start-up of the first phase is expected for the end of 2012, according to market conditions.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hydro Aluminium Extrusion. (2019, March 18). Vale and DUBAL Partner in Alumina Project. AZoM. Retrieved on April 21, 2024 from

  • MLA

    Hydro Aluminium Extrusion. "Vale and DUBAL Partner in Alumina Project". AZoM. 21 April 2024. <>.

  • Chicago

    Hydro Aluminium Extrusion. "Vale and DUBAL Partner in Alumina Project". AZoM. (accessed April 21, 2024).

  • Harvard

    Hydro Aluminium Extrusion. 2019. Vale and DUBAL Partner in Alumina Project. AZoM, viewed 21 April 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.